NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50

Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it

Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:

“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.

In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.

  • Europe’s dependence on US plasma
  • Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
  • The pitfalls of “one-size-fits-all” approach
  • The importance of collaboration

If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.

International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”

Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it

Read more here.

Stay updated with Hemostasis Today.

Critical Juncture Europe’s Plasma Supply Chain Health Hematology Hemostasis Hemostasis Today International Plasma Awareness week Marilena Vrana Medicine The Brussels Times
NewsFeed